Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
4   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

Luigi

Naldi

,

MD

Consultant Dermatologist
San Raffaele Hospital
Milan
,
Italy
Councilor Since: March 1, 2012
IPC Councilor
Request an Update
Dr. Luigi Naldi earned a diploma in Classical Studies and a degree in Industrial Design from the Scuola Politecnica di Design in Milan before transitioning to medicine. He graduated as a medical doctor from the University of Pavia in 1981.

From 1984 to 1986, he worked as a junior investigator at the Laboratory of Clinical Pharmacology at the Mario Negri Institute in Milan. In 1988, he moved into clinical practice at the Department of Dermatology, University of Milan, based at Bergamo General Hospital. He qualified as a Full Professor of Dermatology in 2013.

From 2017 to 2024, he held the position of Director of the Department of Dermatology at the General Hospital of Vicenza. He is currently a consultant at San Raffaele Hospital in Milan.

Dr. Naldi has always regarded the clinical setting as the natural laboratory for clinical research. He is a co-founder of the European Dermatoepidemiology Network (EDEN). From 2003 to 2024, he served as Director of Centro Studi GISED, an independent research centre dedicated to promoting integrated clinical research programs in Dermatology.
Last Updated:
06/26/2025

Areas of Interest

The main research area is in clinical epidemiology of major skin disorders and in the evaluation of complex interventions and educational programs at the population level.

Languages Spoken

English, Italian

Involvement with Other Organization(s)

Advisor to the Italian patient association ADIPSO; expert for the European Medicines Agency (EMA); member of the technical expert group for the Regional Health System in the Veneto Region.
Recent publications

Featured

Blog

Focus on Psoriasis: A Report from the 2024 IPC Think Tank Symposium – Psoriasis: The Multiple Facets of a Global…

The 2024 IPC Think Tank Congress Report provides a comprehensive summary of key topics, including the epidemiology of…

Read More

Event

IPC & ARDV Symposium: Psoriasis - A Complex Disease of All Ages.

ROMANIAN ASSOCIATION OF DERMATOLOGY & VENEREOLOGY (ARDV) ANNUAL CONGRESS | BUCHAREST, ROMANIA Friday, November…

November 10, 2023
Learn More or Register

PDF

Focus on Psoriasis – A Report from the 2021 Hybrid Gene to Clinic Congress.

View Report

Blog

Commentary: Coronavirus disease 2019 (COVID‐19)‐associated hospitalization and mortality in patients with…

The safety of treatment for immune-mediated diseases like psoriasis during the COVID-19 pandemic is a matter of…

Read More

PDF

Biosimilars for the Treatment of Patients with Psoriasis: A Consensus Statement from the Biosimilar Working Group of…

View Report

Blog

Commentary: The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway…

Searching for signals of increased risk of infection in specific subgroups is vitally important, especially when…

Read More

Page

Biosimilars for Psoriasis—Experience from Europe.

Over the last several years, major changes have occurred in Europe regarding the use of biosimilars. Somecountries such…

View Report

Page

Biosimilars for Psoriasis: Worldwide Overview of Regulatory Guidelines, Uptake and Implications for Dermatology…

The introduction of biological drugs for the treatment of patients with psoriasis has revolutionized treatment…

View Report

PDF

The Global State of Psoriasis Disease Epidemiology: A Workshop Report.

View Report

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026